A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.


Updates from The Motley Fool

Latest updates on Novavax from Fool.com.  The Fool has written over 100 articles on Novavax.
4 Stocks I'd Avoid at All Costs

Developing and commercializing new drugs involves so many uncertainties that even the finest biot...

3 Stocks to Avoid in Biotech

Image source: Getty Images. Public outrage over escalating drug prices made the biotechnology ind...

3 Top Biotech Stocks to Buy Now

Image source: Getty Images. Back up the truck, let the tailgate down, and load up... with biotech...

5 Top Stocks to Buy in June

Image Source: Getty Images. The official start of summer is nearly here. While stock markets are ...



Stock Performance

View Interactive NVAX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Novavax.
Current Price: $1.43
Prev Close: $1.46
Open: $1.48
Bid: $1.40
Ask: $1.41
Day's Range: $1.37 - $1.49
52wk Range: $1.16 - $8.95
Volume: 4,535,822
Avg Vol 8,913,317
Market Cap: $386M
P/E (ttm): -1.30
EPS (ttm): ($1.12)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Novavax.
CAPS Rating 2 out of 5
 
308 Outperform
83 Underperform
CAPS All Stars
 
45 Outperform
17 Underperform

How do you think Novavax will perform against the market?



You pick for Novavax is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Stanley C. Erck, CEO

95% Approve

Based on 15 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Novavax.

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers